Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease

[Figure: see text]

Detalles Bibliográficos
Autores principales: Spartalis, Michael, Siasos, Gerasimos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167494/
https://www.ncbi.nlm.nih.gov/pubmed/37181392
http://dx.doi.org/10.1016/j.jacasi.2023.01.002
_version_ 1785038690644393984
author Spartalis, Michael
Siasos, Gerasimos
author_facet Spartalis, Michael
Siasos, Gerasimos
author_sort Spartalis, Michael
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-10167494
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101674942023-05-10 Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease Spartalis, Michael Siasos, Gerasimos JACC Asia Original Research [Figure: see text] Elsevier 2023-03-14 /pmc/articles/PMC10167494/ /pubmed/37181392 http://dx.doi.org/10.1016/j.jacasi.2023.01.002 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Spartalis, Michael
Siasos, Gerasimos
Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
title Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
title_full Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
title_fullStr Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
title_full_unstemmed Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
title_short Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
title_sort challenging the “divinity” of aspirin monotherapy for secondary prevention of cardiovascular disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167494/
https://www.ncbi.nlm.nih.gov/pubmed/37181392
http://dx.doi.org/10.1016/j.jacasi.2023.01.002
work_keys_str_mv AT spartalismichael challengingthedivinityofaspirinmonotherapyforsecondarypreventionofcardiovasculardisease
AT siasosgerasimos challengingthedivinityofaspirinmonotherapyforsecondarypreventionofcardiovasculardisease

Ejemplares similares